Childhood Depression Prozac Evidence Tied to Flawed Trial

· Science

A report argues that use of Prozac for childhood depression has been skewed by a single flawed medical trial. The finding raises questions about the evidence base underpinning prescribing in young patients.

Why it matters：If a key trial underlying pediatric antidepressant use is unreliable, it could prompt re-examination of clinical guidelines and regulatory reviews.

Key points

  • A single flawed trial is said to skew the evidence
  • Concerns center on Prozac use for childhood depression

Sources (original reporting)

More stories from this day